Vaccine News and Research

Latest Vaccine News and Research

Predicting the next pandemic

In planning for a future influenza pandemic, most experts agree that two things are known for certain, there will be another pandemic someday, and nobody can predict when.

9 May 2007

Assessment of state immunization requirements for healthcare workers and patients

A new study shows wide state-to-state variations in laws regulating vaccinations for health care workers and patients, setting the stage for future research to determine whether more laws could serve as effective tools to combat infectious diseases.

9 May 2007

New vaccine breakthrough for respiratory syncytial virus

Respiratory syncytial virus (RSV) infection is a widespread infant illness that has been linked to asthma and can be deadly but may be curable by the development of this new vaccine technology by the Sir Albert Sakzewski Virus Research Centre and The University of Queensland's Faculty of Biological and Chemical Sciences.

9 May 2007

Researchers identify immune dysfunction in melanoma patients

Researchers at the Stanford University School of Medicine have begun to shed light on why the human immune system isn't able to stop such cancers as melanoma, suggesting answers that could pave the way for better treatment of this often-fatal illness.

9 May 2007

Sigma-Aldrich acquires Molecular Medicine BioServices

Sigma-Aldrich Corporation has announced that it has acquired Molecular Medicine BioServices Inc. (MMB), a biopharmaceutical contract manufacturing organization (CMO) located in Carlsbad, California, to further enhance the biologics capabilities within its SAFC Pharma business segment.

9 May 2007

FluMist may help reduce the burden of seasonal influenza

MedImmune, Inc. has announced research results showing that use of FluMist(R) (Influenza Virus Vaccine Live, Intranasal) in daycare and school settings may help reduce the burden of seasonal influenza.

9 May 2007

Promising new target for brain tumor therapy

A drug that targets the body's immune cells may be effective in treating malignant brain tumors, according to a new study led by researchers from Duke's Preston Robert Tisch Brain Tumor Center.

9 May 2007

Abbott seeks U.S. and E.U. approvals for Humira as a treatment for juvenile rheumatoid arthritis

Abbott has announced it has simultaneously submitted a supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) and a Type II Variation to the European Medicines Agency (EMEA) seeking approval to market HUMIRA (adalimumab) as a treatment for juvenile rheumatoid arthritis (JRA) in the U.S. and juvenile idiopathic arthritis (JIA) in the European Union (EU).

9 May 2007

Face masks offer little protection from bird flu

According to the U.S. Centers for Disease Control and Prevention the mass wearing of surgical face masks would do little to reduce the rate of infection in the event of an influenza pandemic.

7 May 2007

Oral vaccine prevents prion disease in mice

An oral vaccine can prevent mice from developing a brain disease similar to mad cow disease, according to research presented at the American Academy of Neurology's 59th Annual Meeting in Boston.

4 May 2007

US control strategies may make flu epidemics worse

Regular as clockwork, the flu arrives every year. And, according to the national Centers for Disease Control and Prevention, 5 to 20 percent of the U.S. population on average will come down with it. About 36,000 people will die.

4 May 2007

Prenatal toxicity linked to immune dysfunctions in later life

A Cornell researcher and his wife have conducted the first comprehensive review of later-life diseases that develop in people who were exposed to environmental toxins or drugs either in the womb or as infants.

4 May 2007

LigoCyte Pharmaceuticals presents data showing that immunization with their influenza H1N1-VLP formulation resulted in 100% protection from H1N1 and H3N2

LigoCyte Pharmaceuticals has presented preclinical data showing that immunization with their influenza virus-like particles (VLPs) induced heterosubtypic protection in a virus challenge study.

4 May 2007

Child infections are an increasing concern in affluent countries

Dr Deborah Lehmann, who leads infectious diseases research at the Telethon Institute for Child Health Research, said the findings show that infection is an increasing concern in affluent countries.

4 May 2007

Newer flu vaccines may have been less effective than vaccines used in previous years

A new Harris Poll suggests that the flu vaccine used before last winter may have been less effective than the vaccines used in some previous years.

4 May 2007

Some physicians not purchasing, restricting recipients of Gardasil because of cost, Washington Post reports

Inadequate reimbursement from insurance companies for Merck's human papillomavirus vaccine Gardasil is leading some physicians to refuse to purchase the vaccine and restricting the recipients to those whose insurers have agreed to pay a "reasonable" fee, the Washington Post reports (Boodman, Washington Post , 5/1).

2 May 2007

Some doctors refuse to purchase cervical cancer vaccine because of low reimbursements

Some physicians are refusing to purchase Merck's cervical cancer vaccine Gardasil or are restricting who receives it because they say insurance reimbursements for the vaccine are too low, the Washington Post reports.

2 May 2007

Serious illness among children with sickle cell disease reduced with pneumococcal conjugate vaccine

A vaccine introduced in 2000 has reduced by more than 90 percent the rate of a serious bacterial illness among young children with sickle cell disease (SCD), who are particularly susceptible to it, according to a new study that appears in the June 1 issue of Clinical Infectious Diseases and currently is available online.

2 May 2007

Fred Hutchinson Cancer Research Center establishes new vaccine and disease institute

Fred Hutchinson Cancer Research Center has established a new Vaccine and Infectious Disease Institute to develop and implement prevention strategies for globally important infectious diseases, including HIV, malaria and cancer.

2 May 2007

Generic biologic drugs unlikely to be cheaper than brand-name drugs

Generic versions of a class of medicines called "biologics" would not be significantly cheaper than brand-name versions of the medicines, according to research from professors at Duke University's Fuqua School of Business.

2 May 2007

Vaccine News and Research

Latest Vaccine News and Research

Predicting the next pandemic

Assessment of state immunization requirements for healthcare workers and patients

New vaccine breakthrough for respiratory syncytial virus

Researchers identify immune dysfunction in melanoma patients

Sigma-Aldrich acquires Molecular Medicine BioServices

FluMist may help reduce the burden of seasonal influenza

Promising new target for brain tumor therapy

Abbott seeks U.S. and E.U. approvals for Humira as a treatment for juvenile rheumatoid arthritis

Face masks offer little protection from bird flu

Oral vaccine prevents prion disease in mice

US control strategies may make flu epidemics worse

Prenatal toxicity linked to immune dysfunctions in later life

LigoCyte Pharmaceuticals presents data showing that immunization with their influenza H1N1-VLP formulation resulted in 100% protection from H1N1 and H3N2

Child infections are an increasing concern in affluent countries

Newer flu vaccines may have been less effective than vaccines used in previous years

Some physicians not purchasing, restricting recipients of Gardasil because of cost, Washington Post reports

Some doctors refuse to purchase cervical cancer vaccine because of low reimbursements

Serious illness among children with sickle cell disease reduced with pneumococcal conjugate vaccine

Fred Hutchinson Cancer Research Center establishes new vaccine and disease institute

Generic biologic drugs unlikely to be cheaper than brand-name drugs

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Vaccine News and Research

Latest Vaccine News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in